Roche Pharma launches India’s first 7-minute injectable immunotherapy for lung cancer

Roche Pharma has introduced Tecentriq, India's first under-the-skin immunotherapy for lung cancer. This new injection takes about seven minutes, a significant improvement over lengthy intravenous treatments. This advancement prioritizes patient experience and quality of life. It offers a quicker, easier way for patients to receive vital cancer care. The drug is approved for non-small cell lung cancer.